SynthesisPloS one2018
Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review.
Thomas Grochtdreis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it